HPTN Publications
Looking to submit your manuscript for review?
Your manuscript can be reviewed by our Manuscript Review committee. Get the submission form.
Filter publications by:
Pettifor A, MacPhail C, Selin A, Gomez-Olive FX, Rosenberg M, Wagner RG, Mabuza W, Hughes JP, Suchindran C, Piwowar-Manning E, Wang J, Twine R, Daniel T, Andrew P, Laeyendecker O, Agyei Y, Tollman S, Kahn K, HPTN 068 Protocol Team . HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results.. AIDS Behav. 2016, 20: 1683-82
2016
AIDS Behav
HPTN 068
Phiri MM, Schaap A, Simwinga M, Hensen B, Floyd S, Mulubwa C, Simuyaba M, Chiti B, Bond V, Shanaube K, Fidler S, Hayes R, Ayles H, HPTN 071 (PopART) Study team . Closing the gap: did delivery approaches complementary to home-based testing reach men with HIV testing services during and after the HPTN 071 (PopART) trial in Zambia?. J Int AIDS Soc. 2022, 25: e25855
2022
J Int AIDS Soc
HPTN 071
Pickles M, Cori A, Probert WJM, Sauter R, Hinch R, Fidler S, Ayles H, Bock P, Donnell D, Wilson E, Piwowar-Manning E, Floyd S, Hayes RJ, Fraser C, HPTN 071 (PopART) Study Team . PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial. PLoS Comput Biol. 2021, 17
2021
PLoS Comput Biol
HPTN 071
Pilgrim NA, Evans TM, Czarnogorski M . A Layer Plus Approach to Implementation Research and Collaboration for Long-Acting Injectable Pre-Exposure Prophylaxis for HIV Prevention. Health Promot Pract. 2022, 23: 912-915
2022
Health Promot Pract
HPTN 083
Ping LH, Jabara CB, Rodrigo AG, Hudelson SE, Piwowar-Manning E, Wang L, Eshleman SH, Cohen MS, Swanstrom R . HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. PLoS One. 2013, 8: e71557
2013
PLoS One
HPTN 052
Pitpitan EV, MacKinnon DP, Eaton LA, Smith LR, Wagman J, Patterson TL . Using Novel Approaches to Evaluate Behavioral Interventions: Overlooked Significant HIV Prevention Effects in the HPTN 015 Project EXPLORE. J Acquir Immune Defic Syndr. 2021, 87: 1128-1135
2021
J Acquir Immune Defic Syndr
HIVNET 015
Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH . Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials. 2014, 15: 62-8
2014
HIV Clin Trials
HPTN 061
Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH . Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. J Clin Virol. 2015, 62: 75-9
2015
J Clin Virol